Industry News
Pharmaceutical Industry News
As an FDA official said that the…
As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S. regulator also is examining the safety of shots that protect infants
Over the weekend, the Senate and…
Over the weekend, the Senate and House released the final text of the National Defense Authorization Act for the 2026 fiscal year, tucking in language that would significantly stymie the ability of certain Chinese life
CSL, which earlier this year…
CSL, which earlier this year shelved plans to put its CSL Seqirus vaccine division up for sale, has opened the doors to a new $1 billion cell-based flu shot and antivenom facility in Melbourne.
Ad agency Imre has filled the…
Ad agency Imre has filled the vacancy at the top of its organization, poaching Nadine Lafond from Ogilvy to serve as its CEO.
A proposed combination of Johnson…
A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that could put some pressure on CAR T-cell therapies, including the company’s own Carvykti.
Transformed Gamida Cell has scored…
Transformed Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the cell therapy to treat severe aplastic anemia. The approval comes more than two years after Omisirge’s original FDA nod as the
Despite holding positive phase 3…
Despite holding positive phase 3 data that position its BTK inhibitor Jaypirca for a first-line approval in chronic lymphocytic leukemia, Jacob Van Naarden, president of Lilly Oncology, maintained that the drug’s primary value proposition remains
China’s National Healthcare…
China's National Healthcare Security Administration unveiled its first batch of 19 meds selected for its new Commercial Health Insurance Innovative Drug Catalogue.
Amgen is getting the ball rolling…
Amgen is getting the ball rolling on a far-reaching new partnership that’s set to boost its profile in its hometown of Greater Los Angeles.
UCB plans to file for regulatory…
UCB plans to file for regulatory approval of Fintepla to treat a third epileptic condition “as soon as possible,” the company said, as it reported results of a phase 3 trial in patients with the ultra-rare
Qué beneficios tiene el CBD
Una encuesta entre 5000 usuarios reveló que más del 60 por ciento lo utiliza para la ansiedad. La pregunta clave es: ¿de verdad ayuda?
After five years of follow-up on…
After five years of follow-up on its hemophilia B gene therapy Hemgenix, CSL found that a one-time dose cut down on annualized bleeding rates by 90% by the fifth year in its Hope-B study.
Mark Cuban, the co-founder of…
Mark Cuban, the co-founder of online pharmacy Cost Plus Drugs, says his company would produce generic drugs in the U.S. if the FDA eliminated approval fees.
Pfizer has unveiled phase 3…
Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its competition with Sanofi’s Qfitlia and Novo Nordisk’s Alhemo.
After a record-setting October…
After a record-setting October that easily dwarfed all preceding months in the year, TV drug ad spending found a happy medium in November.
With FDA approval to treat…
With FDA approval to treat marginal zone lymphoma, Bristol Myers Squibb’s Breyanzi has become the first CAR-T therapy in the indication, as well as the first CAR-T to reach the market for five different types
On “The Top Line,” EY’s Arda…
On “The Top Line,” EY’s Arda Ural talks with Fierce Pharma about biopharma dealmaking trends, valuation shifts and what the industry should expect in 2026.
Halozyme is seeing some progress…
Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & Co.'s new version of Keytruda. A court in Germany ordered the pharma giant to halt Keytruda
The FDA is investigating a safety…
The FDA is investigating a safety signal from Takeda’s rare disease med Adzynma. Otsuka won a first-in-class FDA approval to enter the crowded IgA nephropathy field. Daiichi Sankyo won reversal of an unfavorable ruling in
Avalere Health has hired Sarah…
Avalere Health has hired Sarah Hall as president of U.S. marketing, tapping the direct-to-consumer expert to lead its team through a “politically dynamic” period.